See more Colostrum is not specifically prohibited, however it may contain growth factors which are prohibited and may influence the outcome of anti-doping tests
The consistency of the safety profile across short-term and long-term trials suggests that AOD-9604 does not produce cumulative toxicity or delayed adverse effects that emerge only with chronic administration
Research Dose Ranges Preclinical animal studies: 110 mcg/kg (nanogram to microgram range) once or twice daily Extrapolated human equivalent range commonly discussed in clinical literature: 200500 mcg/day Human pilot IV data: doses up to 20 mg were tolerated without adverse effects in two healthy adults (Lee & Burgess, 2025) though this is far above typical outpatient dosing Protocol: Musculoskeletal / Connective Tissue Healing For tendon, ligament, or muscle injury recovery, the standard approach in clinical functional medicine practice involves: SubQ injection at 200500 mcg once daily , injected near (not into) the injury site Cycle length: typically 48 weeks , with reassessment Often combined with TB-500 (thymosin beta-4) for synergistic tissue remodeling the BPC+TB stack Best results seen alongside physical therapy, not as a substitute for it Protocol: Gut and GI Mucosal Healing For IBD, gut permeability, NSAID damage, or H
FIGURE 3 The characteristics of each estrous cycle of rats can be accurately identified under the microscope: 1) Proestrus, characterized mainly by nucleated epithelial cells and a few keratinocytes with missing nuclei
Biomarker studies: establishing senescent cell burden diagnostic (e.g., imaging, blood markers) to monitor effect and guide dosing
We also care for many individuals with digestive disorders like Crohns disease or celiac disease, which can make it challenging to get enough B12 from diet alone
